Clinical Trial Update: MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study (MAGNAM) comparing magnesium sulfate to amiodarone for new-onset atrial fibrillation in critical care, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)
• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Atrial Fibrillation New Onset | Phase 3 | Status: RECRUITING